[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350591-105":59,"doc-detail-350591-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","controlled-generation-of-dehydroascorbic-acid-a-new-mechanistic-framework-for-high-dose-vitamin-c-anticancer-therapy","Controlled Generation of Dehydroascorbic Acid - A New Mechanistic Framework for High-Dose Vitamin C Anticancer Therapy","","This article reviews pharmacological strategies targeting key metabolic pathways in cancer cells and emphasizes inherent limitations such as metabolic plasticity and limited selectivity. It proposes a global redox-based approach using high-dose vitamin C, where vitamin C is oxidized to dehydroascorbic acid (DHA). Although DHA cannot be given directly due to instability, it can be generated in situ in circulation and taken up by cancer cells, perturbing redox-sensitive processes, depleting NADPH, and collapsing cellular redox homeostasis. A mechanistic framework is presented to enable a more robust clinical anticancer strategy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/controlled-generation-of-dehydroascorbic-acid-a-new-mechanistic-framework-for-high-dose-vitamin-c-anticancer-therapy/350591/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/controlled-generation-of-dehydroascorbic-acid-a-new-mechanistic-framework-for-high-dose-vitamin-c-anticancer-therapy/350591.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do single-target metabolic anticancer strategies often underperform?","Question",{"text":112,"@type":113},"Tumor cells can compensate via metabolic flexibility, alternative pathways, altered nutrient use, and stress-response mechanisms. In addition, inhibiting one target is often limited by toxicity to normal tissues, preventing complete pathway suppression in patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does high-dose vitamin C relate to dehydroascorbic acid (DHA) in the proposed framework?",{"text":117,"@type":113},"The approach relies on vitamin C being oxidized to DHA. Because DHA cannot be administered directly due to instability, it is proposed to be generated in situ within the circulatory system and then taken up by cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular effects does DHA have after uptake by cancer cells?",{"text":121,"@type":113},"DHA perturbs multiple redox-sensitive processes, leading to depletion of NADPH and collapse of cellular redox homeostasis. This disruption is presented as a route to more robust and clinically effective anticancer activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350591,1790304604,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nControlled Generation of Dehydroascorbic Acid: A New Mechanistic Framework for High-Dose Vitamin CAnticancer Therapy  \nAlexander V. Peskin   \nAcademic Editor: Dooil Jeoung  \nReceived: 22 June 2026  \nRevised: 26 June 2026  \nAccepted: 26 June 2026  \nPublished: 3 July 2026  \nCopyright: © 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nCentre for Redox Biology and Medicine, Department of Pathology and Biomedical Science, Mtai  \nHora—University of Otago Christchurch, Christchurch 8011, New Zealand; [alexander.peskin@otago.ac.nz](alexander.peskin@otago.ac.nz)  \nAbstract  \nThis article reviews pharmacological strategies targeting key metabolic pathways in cancer cells and highlights their inherent limitations, including metabolic plasticity and lack of selectivity. It is proposed that these vulnerabilities can be addressed through a global redoxbased approach using high-dose vitamin C. Evidence suggests that the anticancer activity of vitamin C is mediated by its oxidation to dehydroascorbic acid (DHA) . Although DHA cannot be administered directly due to its instability, it can be generated in situ within the circulatory system. Once taken up by cancer cells, DHA perturbs multiple redox-sensitive processes, leading to depletion of NADPH and collapse of cellular redox homeostasis. We present a mechanistic framework outlining how controlled generation of DHA may enable a more robust and clinically effective anticancer strategy.  \nKeywords: cancer; vitamin C; dehydroascorbic acid; hydrogen peroxide; thiols; NADPH  \n“What is now proved was once only imagined”  \nWilliam Blake (The Marriage of Heaven and Hell)  \n1. Introduction  \nA recurring limitation of many metabolic anticancer strategies is that they focus on a single enzyme, pathway, or nutrient dependency. Although such targets are often essential under experimental conditions, tumour cells possess extensive metabolic flexibility and can compensate through alternative pathways, altered nutrient utilisation, or activation of stress-response mechanisms [1–3] . In addition, inhibition of a single target rarely occurs in isolation and is frequently limited by toxicity to normal tissues, preventing complete pathway suppression in patients. These considerations suggest that a more effective strategy may be to impose simultaneous pressure on multiple metabolic processes that collectively support tumour survival. Rather than targeting a single pathway, disruption of the cellular reducing environment has the potential to affect several interconnected systems, including glucose metabolism, thiol homeostasis, DNA synthesis, and methionine metabolism.  \nThis paper reviews several metabolic strategies explored to date and proposes an alternative concept: controlled oxidation of vitamin C to dehydroascorbic acid (DHA) as a means of simultaneously perturbing multiple redox-sensitive metabolic pathways, thereby promoting collapse of tumour redox homeostasis through depletion of intracellular reducing capacity.  \n2. Glucose Metabolism  \nThe first identified metabolic difference in cancer cells was their dependence on glucose, even in the presence of oxygen, as the main energy source, coupled with lactate production [4,5] . This phenomenon, known as the Warburg effect, has been consistently observed in cancer cells of various tissue origins [6] .  \nInhibition of increased glycolysis in tumours has been considered and targeted for anticancer treatment. Extensive reviews on research on inhibitors of pathways related to glucose metabolism and using the knowledge for patient treatment are available [7–11] . Here we discuss some of the most promising treatments as examples to estimate how progress in this field could lead to health benefits.  \n2.1. 2-Deoxyglucose  \n2-Deoxyglucose (2-DG) is a competitive inhibitor of glucose metabolism [12] . After uptake ","cbCaiiiXr7PHbX4l","https://ap.wps.com/l/cbCaiiiXr7PHbX4l","pdf",1918335,15,"English","# Introduction\n## Glucose Metabolism\n### 2-Deoxyglucose\n### Lonidamine\n### 3-Bromopyruvate\n## Thiols","[{\"question\":\"Why do single-target metabolic anticancer strategies often underperform?\",\"answer\":\"Tumor cells can compensate via metabolic flexibility, alternative pathways, altered nutrient use, and stress-response mechanisms. In addition, inhibiting one target is often limited by toxicity to normal tissues, preventing complete pathway suppression in patients.\"},{\"question\":\"How does high-dose vitamin C relate to dehydroascorbic acid (DHA) in the proposed framework?\",\"answer\":\"The approach relies on vitamin C being oxidized to DHA. Because DHA cannot be administered directly due to instability, it is proposed to be generated in situ within the circulatory system and then taken up by cancer cells.\"},{\"question\":\"What cellular effects does DHA have after uptake by cancer cells?\",\"answer\":\"DHA perturbs multiple redox-sensitive processes, leading to depletion of NADPH and collapse of cellular redox homeostasis. This disruption is presented as a route to more robust and clinically effective anticancer activity.\"}]","Controlled Generation of Dehydroascorbic Acid - A New Mechanistic Framework for High-Dose Vitamin C Anticancer Therapy | PDF",1790089773,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/491c55a4eed6733098621dac2c4fdb46.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72dce025f5c4095f16a45e59f9d6054b.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4a1d4110a23c6ba04e2a110af31b8fd.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/919a50da3d829589bcc7810fd8799731.webp",980,1385]